{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:56:08Z","timestamp":1790693768429,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,15]]},"DOI":"10.7759\/cureus.17187","type":"journal-article","created":{"date-parts":[[2021,8,15]],"date-time":"2021-08-15T10:03:50Z","timestamp":1629021830000},"source":"Crossref","is-referenced-by-count":10,"title":["Extra-Intestinal Manifestations of Inflammatory Bowel Disease"],"prefix":"10.7759","author":[{"given":"Aliya H","family":"Sange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubashira K","family":"Sarnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srimy","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasaswi","family":"Pisipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarayoo","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naqvi","family":"Syed Gaggatur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Sange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2018.08.008","article-title":"Early-onset inflammatory bowel disease","volume":"39","author":"Kelsen JR","year":"2019","unstructured":"Kelsen JR, Russo P, Sullivan KE. Early-onset inflammatory bowel disease. Immunol Allergy Clin North Am. 2019, 39:63-79. 10.1016\/j.iac.2018.08.008","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8111970","article-title":"History of inflammatory bowel diseases","volume":"8","author":"Actis GC","year":"2019","unstructured":"Actis GC, Pellicano R, Fagoonee S, Ribaldone DG. History of inflammatory bowel diseases. J Clin Med. 2019, 8:1970. 10.3390\/jcm8111970","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/0102-672020180001e1374","article-title":"The importance of colonoscopy in inflammatory bowel diseases","volume":"31","author":"Passos MA","year":"2018","unstructured":"Passos MA, Chaves FC, Chaves-Junior N. The importance of colonoscopy in inflammatory bowel diseases. Arq Bras Cir Dig. 2018, 31:e1374. 10.1590\/0102-672020180001e1374","journal-title":"Arq Bras Cir Dig"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky DK","year":"2002","unstructured":"Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002, 347:417-29. 10.1056\/NEJMra020831","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"12","author":"Baumgart DC","year":"2007","unstructured":"Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007, 12:1641-57. 10.1016\/S0140-6736(07)60751-X","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/35079114","article-title":"A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease","volume":"411","author":"Ogura Y","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N, et al.. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001, 411:603-6. 10.1038\/35079114","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Zhang YZ","year":"2014","unstructured":"Zhang YZ, Li YY. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014, 20:91-9. 10.3748\/wjg.v20.i1.91","journal-title":"World J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv060","article-title":"A reappraisal of the ileo-rectal anastomosis in ulcerative colitis","volume":"9","author":"Myrelid P","year":"2015","unstructured":"Myrelid P, \u00d8resland T. A reappraisal of the ileo-rectal anastomosis in ulcerative colitis. J Crohns Colitis. 2015, 9:433-8. 10.1093\/ecco-jcc\/jjv060","journal-title":"J Crohns Colitis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-017-0724-z","article-title":"Inflammatory bowel disease in primary immunodeficiencies","volume":"17","author":"Kelsen JR","year":"2017","unstructured":"Kelsen JR, Sullivan KE. Inflammatory bowel disease in primary immunodeficiencies. Curr Allergy Asthma Rep. 2017, 17:57. 10.1007\/s11882-017-0724-z","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nri3583","article-title":"Mucosal immunology: Bacteria get T(Reg) cells into shape","volume":"14","author":"Kugelberg E","year":"2014","unstructured":"Kugelberg E. Mucosal immunology: Bacteria get T(Reg) cells into shape. Nat Rev Immunol. 2014, 14:2-3. 10.1038\/nri3583","journal-title":"Nat Rev Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2009.10.004","article-title":"Human intestinal microbiota and healthy ageing","volume":"9","author":"Tiihonen K","year":"2010","unstructured":"Tiihonen K, Ouwehand AC, Rautonen N. Human intestinal microbiota and healthy ageing. Ageing Res Rev. 2010, 9:107-16. 10.1016\/j.arr.2009.10.004","journal-title":"Ageing Res Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpdhp.2015.06.015","article-title":"Infectious mimics of inflammatory bowel disease","volume":"21","author":"Bhaijee F","year":"20151","unstructured":"Bhaijee F, Arnold C, Lam-Himlin D, Montgomery EA, Voltaggio L. Infectious mimics of inflammatory bowel disease. Diagn Histopathol. 20151, 21:267-75. 10.1016\/j.mpdhp.2015.06.015","journal-title":"Diagn Histopathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2165\/11638120-000000000-00000","article-title":"Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease","volume":"72","author":"Trikudanathan G","year":"2012","unstructured":"Trikudanathan G, Venkatesh PG, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs. 2012, 72:2333-49. 10.2165\/11638120-000000000-00000","journal-title":"Drugs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i46.7227","article-title":"Extraintestinal manifestations in inflammatory bowel disease","volume":"11","author":"Danese S","year":"2005","unstructured":"Danese S, Semeraro S, Papa A, et al.. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005, 11:7227-36. 10.3748\/wjg.v11.i46.7227","journal-title":"World J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.6.2359","article-title":"The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats","volume":"180","author":"Taurog JD","year":"1994","unstructured":"Taurog JD, Richardson JA, Croft JT, et al.. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994, 180:2359-64. 10.1084\/jem.180.6.2359","journal-title":"J Exp Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka SR","year":"2015","unstructured":"Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015, 21:1982-92. 10.1097\/MIB.0000000000000392","journal-title":"Inflamm Bowel Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178675","article-title":"Genetic markers may predict disease behavior in patients with ulcerative colitis","volume":"112","author":"Roussomoustakaki M","year":"1997","unstructured":"Roussomoustakaki M, Satsangi J, Welsh K, et al.. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology. 1997, 112:1845-53. 10.1053\/gast.1997.v112.pm9178675","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200111000-00005","article-title":"Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity","volume":"7","author":"Veloso FT","year":"2001","unstructured":"Veloso FT, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the Vienna classification and clinical activity. Inflamm Bowel Dis. 2001, 7:306-13. 10.1097\/00054725-200111000-00005","journal-title":"Inflamm Bowel Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i22.2702","article-title":"Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?","volume":"17","author":"Veloso FT","year":"2011","unstructured":"Veloso FT. Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?. World J Gastroenterol. 2011, 17:2702-7. 10.3748\/wjg.v17.i22.2702","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199607000-00009","article-title":"Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients","volume":"23","author":"Veloso FT","year":"1996","unstructured":"Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996, 23:29-34. 10.1097\/00004836-199607000-00009","journal-title":"J Clin Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21937","article-title":"Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis","volume":"18","author":"Al-Jarallah K","year":"2012","unstructured":"Al-Jarallah K, Shehab D, Al-Attiyah R, et al.. Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis. Inflamm Bowel Dis. 2012, 18:1655-62. 10.1002\/ibd.21937","journal-title":"Inflamm Bowel Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"21","author":"Braun J","year":"2007","unstructured":"Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007, 21:1379-90. 10.1016\/S0140-6736(07)60635-7","journal-title":"Lancet"},{"key":"ref23","article-title":"Ankylosing spondylitis. An update","volume":"42","author":"Golder V","year":"2013","unstructured":"Golder V, Schachna L. Ankylosing spondylitis. An update. Aust Fam Physician. 2013, 42:780-4.","journal-title":"Aust Fam Physician"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3171\/FOC\/2008\/24\/1\/E2","article-title":"A review of the pathogenesis of ankylosing spondylitis","volume":"24","author":"Dakwar E","year":"2008","unstructured":"Dakwar E, Reddy J, Vale FL, Uribe JS. A review of the pathogenesis of ankylosing spondylitis. Neurosurg Focus. 2008, 24:E2. 10.3171\/FOC\/2008\/24\/1\/E2","journal-title":"Neurosurg Focus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0811-5","article-title":"Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease","volume":"29","author":"Beslek A","year":"2009","unstructured":"Beslek A, Onen F, Birlik M, et al.. Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease. Rheumatol Int. 2009, 29:955-7. 10.1007\/s00296-008-0811-5","journal-title":"Rheumatol Int"},{"key":"ref26","article-title":"Treatment of ankylosing spondylitis","volume":"1","author":"Clegg DO","year":"2006","unstructured":"Clegg DO. Treatment of ankylosing spondylitis. J Rheumatol. 2006, 1:24-31.","journal-title":"J Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2017160121","article-title":"Beyond the bowel: extraintestinal manifestations of inflammatory bowel disease","volume":"37","author":"Olpin JD","year":"2017","unstructured":"Olpin JD, Sjoberg BP, Stilwill SE, Jensen LE, Rezvani M, Shaaban AM. Beyond the bowel: extraintestinal manifestations of inflammatory bowel disease. Radiographics. 2017, 37:1135-60. 10.1148\/rg.2017160121","journal-title":"Radiographics"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy339","article-title":"The prevalence and clinical associations of subclinical sacroiliitis in inflammatory bowel disease","volume":"25","author":"Kelly OB","year":"2019","unstructured":"Kelly OB, Li N, Smith M, Chan J, Inman RD, Silverberg MS. The prevalence and clinical associations of subclinical sacroiliitis in inflammatory bowel disease. Inflamm Bowel Dis. 2019, 25:1066-71. 10.1093\/ibd\/izy339","journal-title":"Inflamm Bowel Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.05108.x","article-title":"Clinical and genetic factors associated with sacroiliitis in Crohn's disease","volume":"23","author":"Peeters H","year":"2008","unstructured":"Peeters H, Vander Cruyssen B, Mielants H, et al.. Clinical and genetic factors associated with sacroiliitis in Crohn's disease. J Gastroenterol Hepatol. 2008, 23:132-7. 10.1111\/j.1440-1746.2007.05108.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref30","article-title":"Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort","volume":"101","author":"Nguyen GC","year":"20061","unstructured":"Nguyen GC, Torres EA, Regueiro M, et al.. Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort. Am J Gastroenterol. 20061, 101:1012-23.","journal-title":"Am J Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-005-0044-9","article-title":"The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease","volume":"26","author":"Turkcapar N","year":"2006","unstructured":"Turkcapar N, Toruner M, Soykan I, et al.. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int. 2006, 26:663-8. 10.1007\/s00296-005-0044-9","journal-title":"Rheumatol Int"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment","volume":"13","author":"Schett G","year":"2017","unstructured":"Schett G, Lories RJ, D'Agostino MA, Elewaut D, Kirkham B, Soriano ER, McGonagle D. Enthesitis: from pathophysiology to treatment. Nat Rev Rheumatol. 2017, 13:731-41. 10.1038\/nrrheum.2017.188","journal-title":"Nat Rev Rheumatol"},{"key":"ref33","article-title":"Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study)","volume":"29","author":"Palm O","year":"2002","unstructured":"Palm O, Moum B, Ongre A, Gran JT. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol. 2002, 29:511-5.","journal-title":"J Rheumatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2019-epa.680","article-title":"P331 extraintestinal manifestations of pediatric inflammatory bowel disease: a Tunisian single-center experience","volume":"104","author":"Rabeh RB","year":"2019","unstructured":"Rabeh RB, Othman AB, Bouyahya O, Mrad SM, Boukthir S. P331 extraintestinal manifestations of pediatric inflammatory bowel disease: a Tunisian single-center experience. Arch Dis Child. 2019, 104:A290. 10.1136\/archdischild-2019-epa.680","journal-title":"Arch Dis Child"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5070\/D34829t6rn","article-title":"Erythema nodosum","volume":"8","author":"Requena L","year":"2002","unstructured":"Requena L, Requena C. Erythema nodosum. Dermatol Online J. 2002, 8:4. 10.5070\/D34829t6rn","journal-title":"Dermatol Online J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181ca4db4","article-title":"Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity","volume":"51","author":"Dotson JL","year":"2010","unstructured":"Dotson JL, Hyams JS, Markowitz J, et al.. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. J Pediatr Gastroenterol Nutr. 2010, 51:140-5. 10.1097\/MPG.0b013e3181ca4db4","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20604","article-title":"Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease","volume":"15","author":"Jose FA","year":"2009","unstructured":"Jose FA, Garnett EA, Vittinghoff E, et al.. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2009, 15:63-8. 10.1002\/ibd.20604","journal-title":"Inflamm Bowel Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-19","article-title":"Pyoderma gangrenosum - a review","volume":"2","author":"Wollina U","year":"2007","unstructured":"Wollina U. Pyoderma gangrenosum - a review. Orphanet J Rare Dis. 2007, 2:19. 10.1186\/1750-1172-2-19","journal-title":"Orphanet J Rare Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20807","article-title":"Mucocutaneous manifestations in inflammatory bowel disease","volume":"15","author":"Y\u00fcksel I","year":"2009","unstructured":"Y\u00fcksel I, Ba\u015far O, Ataseven H, et al.. Mucocutaneous manifestations in inflammatory bowel disease. Inflamm Bowel Dis. 2009, 15:546-50. 10.1002\/ibd.20807","journal-title":"Inflamm Bowel Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv232","article-title":"Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease","volume":"10","author":"Karmiris K","year":"2016","unstructured":"Karmiris K, Avgerinos A, Tavernaraki A, et al.. Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease. J Crohns Colitis. 2016, 10:429-36. 10.1093\/ecco-jcc\/jjv232","journal-title":"J Crohns Colitis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i32.5836","article-title":"Ophthalmic manifestations in patients with inflammatory bowel disease: a review","volume":"23","author":"Troncoso LL","year":"2017","unstructured":"Troncoso LL, Biancardi AL, de Moraes HV Jr, Zaltman C. Ophthalmic manifestations in patients with inflammatory bowel disease: a review. World J Gastroenterol. 2017, 23:5836-48. 10.3748\/wjg.v23.i32.5836","journal-title":"World J Gastroenterol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2012.10.013","article-title":"Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease","volume":"45","author":"Cloch\u00e9 V","year":"2013","unstructured":"Cloch\u00e9 V, Buisson A, Tr\u00e9chot F, et al.. Ocular symptoms are not predictive of ophthalmologic inflammation in inflammatory bowel disease. Dig Liver Dis. 2013, 45:195-9. 10.1016\/j.dld.2012.10.013","journal-title":"Dig Liver Dis"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156666","article-title":"Pain in IBD patients: very frequent and frequently insufficiently taken into account","volume":"11","author":"Zeitz J","year":"2016","unstructured":"Zeitz J, Ak M, M\u00fcller-Mottet S, et al.. Pain in IBD patients: very frequent and frequently insufficiently taken into account. PLoS One. 2016, 11:e0156666. 10.1371\/journal.pone.0156666","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12947","article-title":"Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region)","volume":"30","author":"R\u00f6nnblom A","year":"2015","unstructured":"R\u00f6nnblom A, Holmstr\u00f6m T, Tangh\u00f6j H, Rorsman F, Sj\u00f6berg D. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region). J Gastroenterol Hepatol. 2015, 30:1288-92. 10.1111\/jgh.12947","journal-title":"J Gastroenterol Hepatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.14740\/gr990w","article-title":"Hepatobiliary manifestations and complications in inflammatory bowel disease: a review","volume":"11","author":"Fousekis FS","year":"2018","unstructured":"Fousekis FS, Theopistos VI, Katsanos KH, Tsianos EV, Christodoulou DK. Hepatobiliary manifestations and complications in inflammatory bowel disease: a review. Gastroenterology Res. 2018, 11:83-94. 10.14740\/gr990w","journal-title":"Gastroenterology Res"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S45466","article-title":"Nephrolithiasis in patients with inflammatory bowel disease in the community","volume":"6","author":"Cury DB","year":"2013","unstructured":"Cury DB, Moss AC, Schor N. Nephrolithiasis in patients with inflammatory bowel disease in the community. Int J Nephrol Renovasc Dis. 2013, 6:139-42. 10.2147\/IJNRD.S45466","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2019.02.001","article-title":"Nephrolithiasis","volume":"46","author":"Mayans L","year":"2019","unstructured":"Mayans L. Nephrolithiasis. Prim Care. 2019, 46:203-12. 10.1016\/j.pop.2019.02.001","journal-title":"Prim Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/67345-extra-intestinal-manifestations-of-inflammatory-bowel-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:14Z","timestamp":1707507254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/67345-extra-intestinal-manifestations-of-inflammatory-bowel-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,15]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.17187","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,15]]}}}